Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
about
Local ablative treatments for hepatocellular carcinoma: An updated reviewHepatocellular carcinoma: A comprehensive reviewDifferentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular Carcinoma.Laser ablation for small hepatocellular carcinoma: State of the art and future perspectivesRisk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection.Long-term prognosis after resection of cryptogenic hepatocellular carcinomaIndependent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy.ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative ResectionExpression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma.Management of hepatocellular carcinoma: Enlightening the gray zones.eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study.Prognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue.Loco-regional treatment of hepatocellular carcinoma.Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability.Chemoembolization in patients with hepatocellular carcinoma.Hepatocellular carcinoma review: current treatment, and evidence-based medicine.Prognostic factors for hepatocellular carcinoma recurrence.The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review.Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.Impact of Viral Etiology on Postoperative De Novo Recurrence After Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Patients.Conditional survival analysis of hepatocellular carcinoma patients treated with radiofrequency ablation.Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.Preoperative ultrasound features as prognostic factors for patients with hepatocellular carcinoma.Prognostic impact of surgical margin in patients with hepatocellular carcinoma: A meta-analysis.Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.Improved diagnostic imaging and interventional therapies prolong survival after resection for hepatocellular carcinoma in cirrhosis: the university of bologna experience over 10 years.Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation.The 4th Asia-Pacific Primary Liver Cancer Expert MeetingEfficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.Prognostic Value of Long Non-Coding RNA HULC and MALAT1 Following the Curative Resection of Hepatocellular Carcinoma.Factors predicting overall response and overall survival in hepatocellular carcinoma patients undergoing balloon-occluded transcatheter arterial chemoembolization: A retrospective cohort study.Association of tumor-associated fibroblasts with progression of hepatocellular carcinoma.Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.Primary liver resection for patients with cirrhosis and hepatocellular carcinoma: the role of surgery in BCLC early (A) and intermediate stages (B).Phosphorylated p38 and JNK MAPK proteins in hepatocellular carcinoma.Chronic Hypoxia Emerging as One of the Driving Forces behind Gene Expression and Prognosis of Hepatocellular Carcinoma
P2860
Q28078113-6012E205-8524-4618-B428-5C5F85C7E4C7Q28087638-30A87B71-B3FD-4D8F-B0B5-56B2B8D6A134Q33921981-3B9DC6D5-D6AA-4059-A022-F1140FCBDB8BQ35370564-759C002D-F904-4F0D-A311-B27F94835703Q35469103-3D0A9909-72E4-4086-A5F8-352A99A5992CQ35811052-447E7DA5-1AE6-4D18-9959-CEB743048E68Q36102829-84E86006-A028-410C-911C-044B03FD2550Q36186943-7ADB9A39-B2AD-46CB-99C8-D451E56DD908Q36186975-27F84590-C32F-4F28-A747-0410B827649EQ36955647-FC63A28C-6A10-49C9-8DC3-0900AA063C05Q37317462-05453C33-8989-42EC-B352-9866254AE4ADQ37582227-9A2CC432-C59B-4802-99FD-45C704FF4431Q37766546-A6D802DE-8BE7-49CF-96F1-0EB8E7DFA794Q37895618-DB6BD740-75BD-4244-B38B-3AA362299937Q38059620-5EE5A5D9-E65D-47A9-A2F0-95B50B9447B1Q38155505-B2AA1C8C-7EE9-43DA-98F9-82CAC154D7B2Q38207012-7761E371-A358-498F-BDD7-C94EE481EC67Q38216004-E25F41CB-DA6E-4933-A3AD-29DE1C705B9DQ38217657-3EB5F25C-92F6-4674-858A-4D699BCC1137Q38668755-A1EAFB78-7E8A-42D1-A63C-1483EF4897B0Q39041689-E700C2B0-DF31-4569-97C2-55970EACEBA5Q39084340-8DAE2870-DD8C-4877-8041-657BCBC260A1Q39648514-A273781C-1BDF-48C1-82BA-128528883D9AQ41054698-EA898302-4363-4071-9B35-93C6A6E9DEA4Q41603521-56CCB9A5-7167-4DB7-AB19-1D45A767F3C3Q41761152-4074D184-615C-4A9E-811A-187D237F6CD2Q42233205-AD568F3C-EC05-4535-8FDA-D44006572761Q43587535-349BD3FD-AFED-4F58-9232-8687D1373586Q44680576-2DE54234-BFF0-41FA-80EA-9ADAF01F5B53Q45074449-33A5DD41-D318-4986-ADA6-EB8E6ABB66EEQ45370256-E52764DD-CD73-480C-A1EA-B9CB7AF0C60EQ47121517-A349419D-C7C6-4E62-ABDF-5486DCEF5470Q47139481-F8D5B5E5-43E1-4BA4-9D87-43C3F2893124Q47171682-96D21BC5-D4CD-4A8A-B3E7-75BAF47B5A5CQ50207399-4CE4BA10-5DA4-4498-8218-CB266211030FQ50883910-E6AFFE37-72C4-498C-8E70-6CE25B2C9FF2Q51731357-02AAB05D-948C-401F-9ED6-3245A798D680Q52815167-9E6EDF2E-C7FA-4D7E-B2AD-1A1A8DEC82A7Q54479908-D9F34BB1-637A-4AF3-A2C4-D142F4E448D8Q58689162-E857AB27-C8AE-4F08-B0DE-37B3D6F16005
P2860
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Comparison of recurrence of he ...... rveilled cirrhotic population.
@ast
Comparison of recurrence of he ...... rveilled cirrhotic population.
@en
Comparison of recurrence of he ...... rveilled cirrhotic population.
@nl
type
label
Comparison of recurrence of he ...... rveilled cirrhotic population.
@ast
Comparison of recurrence of he ...... rveilled cirrhotic population.
@en
Comparison of recurrence of he ...... rveilled cirrhotic population.
@nl
prefLabel
Comparison of recurrence of he ...... rveilled cirrhotic population.
@ast
Comparison of recurrence of he ...... rveilled cirrhotic population.
@en
Comparison of recurrence of he ...... rveilled cirrhotic population.
@nl
P2093
P50
P1476
Comparison of recurrence of he ...... rveilled cirrhotic population.
@en
P2093
Antonio Daniele Pinna
Eugenio Caturelli
Luigi Bolondi
Luisa Benvegnù
Matteo Cescon
Matteo Ravaioli
P2888
P304
P356
10.1245/S10434-008-0232-4
P577
2008-11-26T00:00:00Z
P6179
1007143395